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Abstract
Objective: Inhalation anesthetics increase heart rate (HR) in vivo in both 
animals and humans but decrease heart rate in isolated hearts. Clinical 
studies indicate that insulin-dependent diabetes mellitus is associated 
with alterations in autonomic nervous system control of cardiovascular 
function. The specific aim of this study was to elucidate the effects of dif-
ferent inhalation anesthetics on cardiovascular autonomic function in 
diabetic rats.
Materials and Methods: We measured blood pressure variability (BPV) 
in streptozotocin (STZ, 60 mg/kg, i.p.)-induced diabetic Sprague-Dawley 
rats and vehicle control groups exposed to different inhalation anesthet-
ics (halothane, desflurane and sevoflurane) and BPV was recorded until 
the recovery stage. Frequency-domain analysis of telemetric systemic 
arterial pressure and pulse-pulse interval were applied to quantify the 
parameters of BPV. High frequency power (HF) was regarded as cardiac 
vagal modulation. Low frequency power of BPV (BLF) was referred to as 
vascular sympathetic modulation. Normalized low-frequency power (LF%) 
of the spectrogram of the RR interval was regarded as cardiac sympa-
thetic modulation.
Results: STZ-induced diabetes was associated with a significant reduc-
tion of HR but not consistently with a higher HF among these volatile 
anesthetics. BLF was significantly decreased at one minimum alveolar 
concentration (MAC) of desflurane when compared with halothane and 
sevoflurane in the STZ-induced diabetic group. We found an early recov-
ery of the BLF to awake stage baseline values 30 minutes post-anesthesia 
for sevoflurane, although it was not significant when compared with the 
other two anesthetics. However, the LF% significantly recovered to 80% 
of awake baseline values with desflurane and sevoflurane when com-
pared with halothane 30 minutes post-anesthesia.
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Conclusion: The components of sympathetic regulation (BLF and LF%) 
may be an early sign of hemodynamic recovery to the awake stage during 
anesthesia in STZ-induced diabetic rats. Our results provide an indication 
for clinical anesthetic choice in diabetes patients receiving anesthesia. 
[Tzu Chi Med J 2009;21(4):302–309]
1. Introduction
Insulin-dependent diabetes mellitus (IDDM) alters sys-
temic autonomic function and autonomic nervous 
system (ANS) control of cardiovascular function. Clin-
ical studies suggest that parasympathetic nervous 
control of the heart is diminished in diabetics and 
sympathetic neuropathy often occurs in these indi-
viduals [1–4]. Evidence shows that both branches of 
the ANS are impaired [4]. In addition, IDDM is associ-
ated with neuronal alternations that develop progres-
sively with the duration of disease [1]. Subclinical 
changes have been observed early after diagnosis in 
young individuals with overt neuropathy [5,6]. In ani-
mal studies, streptozotocin (STZ)-induced diabetes 
has been shown to result in resting bradycardia, a 
diminished circadian variation in heart rate (HR) and 
decreased cardiac sympathetic and parasympathetic 
control under resting conditions [7,8].
Several studies have reported hemodynamic in-
stability in patients with autonomic dysfunction dur-
ing anesthetic induction and maintenance [9–14]. 
Impaired regulation of blood pressure and HR may 
cause imbalances in myocardial oxygen demand and 
supply, and these may increase surgical risks in dia-
betic patients. Brian et al have shown that the mini-
mal alveolar concentration (MAC) values of halothane, 
isoflurane, and enflurane are diminished in diabetic 
rats compared with control rats [9]. However, Hattori 
et al suggested that the myocardium of diabetic rats 
could be less sensitive to halogenated agents than the 
myocardium of healthy rats [15]. Recently, it was re-
ported that halothane and sevoflurane have greater 
negative inotropic effects in diabetic rats, mainly be-
cause of a significant decrease in myocardium Ca2+ 
sensitivity [16]. All of these results may explain some 
of the reasons for hemodynamic instability in diabe-
tes mellitus (DM) patients during anesthesia.
Power spectral analysis of HR variability (HRV) has 
proven useful in evaluating cardiovascular autonomic 
activity in diabetic patients [17–19]. The main advan-
tage of spectral analysis is the possibility of assessing 
not only the amount of overall variability, but also 
frequency-specific oscillations and the relative impact 
on variability of sympathetic and vagal modulation in 
the heart [19]. The purpose of this study was to in-
vestigate the effects of different volatile anesthetics 
on the neural cardiovascular autonomic regulation 
in STZ-induced diabetic rats.
2. Materials and methods
2.1. Animal preparation
The subcommittee on Research Animal Care of 
Buddhist Tzu Chi University and Tzu Chi General 
Hospital approved the experimental protocol. Exper-
iments were carried out on adult male Sprague-Dawley 
(200–250 g) rats. The rats were obtained from the 
Animal Center of Tzu Chi University with guidelines 
established by the Position of the American Heart 
Association on Research Animal Use. Diabetes was in-
duced in the rats by administration of 60 mg/kg STZ 
i.p. (Sigma, St. Louis, MO, USA) with pH 4.5, and 0.1 M 
citrate buffer. Diabetic mellitus was then confirmed 
by Diastix semiquantitative urine sugar test strips = 
10 g/L [20]. The control group was given an intraperi-
toneal injection of 1 mL/kg citrate buffer solution.
In the telemetry system (model TA11PA-C40; Data 
Sciences, St. Paul, MN, USA), a pressure transmitter 
was implanted to record arterial pressure signals ac-
cording to the methods of Kuo et al [21]. One week 
after diabetes was induced, the rats were anesthe-
tized with pentobarbital sodium (50 mg/kg i.p.) and 
a flexible transmitter catheter was secured surgically 
in the abdominal aorta below the renal arteries point-
ing against the flow. The tip of the probe catheter 
was inserted rostrally by a small hole in the abdomi-
nal wall and fixed in position with a drop of tissue 
glue. The transmitter body was positioned in the ab-
dominal cavity and sutured to the inside of the mus-
cle. After surgery, the rats were given antibiotics 
(chlortetracycline) and housed individually in cages 
for 1 week of recovery. On the day of the recording, a 
30-minute period was allowed for the rat to become 
familiar with the chamber and the experimental ap-
paratus. At the time of the arterial pressure measure-
ments, each cage was placed over the receiver panel 
and connected to a computer for collection of data. 
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The biological signals were then synchronously re-
corded in every rat during the experiment.
STZ-induced diabetes and control rats were divided 
into groups for exposure to halothane, desflurane, or 
sevoflurane. We continuously recorded awake, control 
biological signals (AW) for 30 minutes, and then ad-
ministered 1.0 MAC of the inhalation anesthetics (0.8% 
halothane, 6.0% desflurane and 2.0% sevoflurane) 
for 30 minutes while still recording. We then increased 
the anesthetic concentration to 1.3 MAC (1.2% ha-
lothane, 7.8% desflurane and 2.6% sevoflurane) for 
30 minutes and recorded data. After recording the 
data, the anesthetics were stopped and recording was 
carried out at 30, 60 and 90 minutes post-anesthesia 
(PA30, PA60 and PA90, respectively) until the animals 
were fully awake.
2.2. Cardiovascular variability analysis
Biotelemetry techniques were utilized to monitor car-
diovascular parameters and changes in STZ-induced 
diabetes and control rats during anesthetic exposure. 
Spectral analysis of the mean arterial pressure (MAP) 
and interpulse interval (PPI) signals were monitored 
as an index of autonomic nervous function as previ-
ously reported by Kuo et al [21,22]. The stationary 
MAP and PPI signals were resampled and interpolated 
at a rate of 64 Hz to provide continuity in the time 
domain and were then truncated into successive 16-
second (1024 points) time segments (windows or 
epochs) with 50% overlap. These sequences were 
analyzed with fast Fourier transform after application 
of the Hamming window. We analyzed the MAP and PPI 
signal spectral data according to the following fre-
quency bands. Low-frequency power (BLF; 0.06–0.6 Hz) 
of the MAP spectrogram, high-frequency power (HF; 
0.6–2.4 Hz), and normalized low-frequency power (nu) 
(representing the relative value of the LF power com-
ponent in proportion to the total power minus the very 
low frequency component) of the PPI spectrogram 
were quantified. BLF, LF%, and HF provide markers of 
sympathetic vasomotor activity, cardiac sympathetic 
modulation, and cardiac vagal activity, respectively 
[22–24]. The data length for the sequence analysis is 
56 seconds, which is synchronous with the spectral 
analysis.
2.3. Statistical analysis
Different effects of the same inhalation anesthetic 
between the control and STZ-induced group were 
assessed by unpaired Student t test. The neural reg-
ulation effects of the different inhalation anesthetics 
on STZ-induced diabetic rats were analyzed by one-
way ANOVA, with post hoc comparisons using the 
Student-Newman-Keuls method. Data are presented 
as mean ± standard error of the mean and p < 0.05 
indicates statistical significance.
3. Results
The use of telemetric arterial pressure recordings 
allowed complete and simultaneous measurement 
of arterial pressure signals from which the awake, 
anesthesia and recovery stages of arterial pressure 
variability could be analyzed. There were no significant 
differences in mean blood pressure (MBP; except with 
1.3 MAC sevoflurane, STZ: 96 ± 3 mmHg vs. control: 
86 ± 3 mmHg) or LF% between the control and STZ-
induced diabetic groups (Figs. 1A, 2A, 3A and 1E, 2E, 
3E). HR was significantly decreased in the diabetic 
rats compared with the control group with all three 
anesthetics. This phenomenon occurred not just at 
the awake stage but also during all anesthetic peri-
ods and recovery stages until PA90 (Figs. 1C, 2C, 
3C). The HF component in the STZ-induced group 
was significantly higher than that in the control group 
with halothane exposure in the awake, 1.0 MAC, 1.3 
MAC and PA30 stages (Fig. 1D), but in the desflurane 
and sevoflurane groups this was not significant, al-
though there was a trend towards it being higher 
(Figs. 2D, 3D). The effects of the three volatile anes-
thetics on BLF were different between the groups, 
especially at the recovery stage. BLF in the diabetic 
rats was significantly lower than in the control rats at 
the awake and PA90 stages with exposure to haloth-
ane (Fig. 1B). Nevertheless, BLF was persistently sig-
nificantly lower in the diabetic group than in the 
control group at PA30 and PA60 with desflurane ex-
posure (Figs. 2B, 3B) and at PA30, PA60 and PA90 
with sevoflurane (Fig. 3B).
When we compared the effects of these anesthetics 
in the STZ-induced diabetic rats, we used the awake 
stage (AW) baseline value as the standard and com-
pared each stage as a percentage of the AW value. 
We found that the MBP change was not significant 
(except at the 1 MAC stage where MBP of the desflu-
rane group was significantly lower than that in the 
halothane group) among the three anesthetics dur-
ing all stages in diabetic rats (Table 1). BLF decreased 
most at 1 MAC in the desflurane group and was sig-
nificantly lower than that in the halothane group. BLF 
had an early recovery to the AW stage value in the 
sevoflurane group compared to the halothane and 
desflurane groups (but this was just a trend and was 
not statistically significant). The halothane and des-
flurane groups did not recover to the same percent-
age of AW baseline values until the PA90 stage. There 
were no significant changes in HF and HR among the 
anesthetics in the STZ-induced diabetic rats. LF% was 
significantly higher at PA30 in the desflurane and 
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sevoflurane groups compared with that in the haloth-
ane group (Table 1).
4. Discussion
Data from our study successfully demonstrated the 
dose- and time-dependent effects of inhalation anes-
thetics on sympathetic vasomotor activity and cardiac 
sympathetic modulation in control and STZ-induced 
diabetic rats. However, the effects of different anes-
thetics on cardiac vagal activity were not the same in 
the two groups.
Autonomic neuropathy and cardiovascular dysreg-
ulation are common complications of DM [1]. Dia-
betic patients with autonomic neuropathy have a 
higher mortality than those without autonomic neu-
ropathy [25,26]. ANS dysregulation can be detected 
by modern sensitive methods, even in the early 
stages of DM [1,26]. Javorka et al used spectral anal-
ysis of BPV in young patients with IDDM and found 
impaired parasympathetic control of the HR but no 
difference in blood vessel sympathetic control [1]. 
Previous studies have shown that STZ-induced dia-
betic rats demonstrate lower basal systolic arterial 
pressure and HR and reduced mid-frequency band 
variability of BPV [7,8]. These findings suggested that 
sympathetic modulation of the cardiovascular sys-
tem was impaired. In our study, the diabetic rats also 
showed ANS dysregulation, including lower sympa-
thetic (BLF) vasomotor activity, a lower HR and higher 
parasympathetic (HF) modulation of the cardiovas-
cular system when compared with the controls in the 
awake state. This is consistent with previous studies 
of STZ-induced diabetic rats with ANS dysregulation, 
although there was no significant difference in MBP 
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Fig. 1 — Comparison of parameters between control and 
streptozotocin (STZ)-induced diabetic rats with haloth-
ane anesthesia. *p < 0.05 compared with the control 
group. -- control group; -- STZ-induced diabetic group. 
MBP = mean blood pressure; BLF = low frequency of blood 
pressure variability; HR = heart rate; HF = high frequency; 
LF% = normalized low frequency (nu); AW = awake stage; 
MAC = minimal alveolar concentration; PA30 = post-
anesthesia 30 minutes; PA60 = post-anesthesia 60 minutes; 
PA90 = post-anesthesia 90 minutes.
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between our groups. However, when we compared 
the effects of the three volatile anesthetics in the di-
abetic rats, the results showed a different regulation 
of vascular (BLF) and cardiac (LF%) sympathetic ef-
fects during the anesthetic and recovery stages. 
Sympathetic vasomotor activity regulation seemed 
deepest at 1 MAC with desflurane but not with haloth-
ane and sevoflurane. With desflurane and sevoflu-
rane, cardiac sympathetic modulation recovered early 
to almost 80% of the awake state just 30 minutes 
post-anesthesia. This finding suggested there is de-
creased vasomotor sympathetic activity soon at 1 MAC 
with desflurane in STZ-induced diabetic rats. When 
these rats were given sevoflurane, vasomotor sympa-
thetic activity did not decrease as quickly and car-
diac sympathetic activity recovered early at 30 
minutes post-anesthesia. These results may help cli-
nicians determine which anesthetics to use when 
IDDM patients have surgery.
Volatile anesthetics increase HR in vivo both in 
animals and humans [27–31]. Activation of the sym-
pathetic nervous system may explain the increase in 
HR during volatile anesthesia, which may be caused 
by an increase in traffic of the sympathetic nerves in-
nervating skeletal muscle in humans [32–34]. However, 
activation of the sympathetic nervous system is more 
pronounced during transient than steady state con-
ditions [32]. In our steady state experiments, we saw 
no signs of tachycardia in either group (except in the 
halothane group). Fazan et al showed that basal sys-
tolic arterial pressure and HR were reduced in STZ-
induced diabetic animals in a power spectral analysis 
of BPV and HRV [7]. They suggested that reduction of 
mid-frequency band variability of arterial pressure might 
indicate that sympathetic modulation of the cardio-
vascular system is impaired. In our study, STZ-induced 
diabetic rats also had a reduced HR from the awake 
state to 90 minutes post-anesthesia. In STZ-induced 
Fig. 2 — Comparison of parameters between control and 
streptozotocin (STZ)-induced diabetic rats with desflurane 
anesthesia. *p < 0.05 compared with the control group. -- 
control group; -- STZ-induced diabetic group. MBP = mean 
blood pressure; BLF = low frequency of blood pressure 
variability; HR = heart rate; HF = high frequency; LF% = nor-
malized low frequency (nu); AW = awake stage; MAC = mini-
mal alveolar concentration; PA30 = post-anesthesia 30 
minutes; PA60 = post-anesthesia 60 minutes; PA90 = post-
anesthesia 90 minutes.
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diabetic rats, MAP was significantly decreased with des-
flurane at 1.0 MAC, which is compatible with signifi-
cantly early depressed vasomotor sympathetic activity 
(BLF) with the lowest trend of cardiac sympathetic 
activity (LF%). BLF recovered quickly to the awake state 
just 30 minutes after stopping sevoflurane. Cardiac 
sympathetic activity also returned to almost 80% of 
the awake state 30 minutes post-anesthesia in both 
the sevoflurane and desflurane groups. These results 
suggest that the effects of different volatile anesth-
etics on autonomic neuromodulation in STZ-induced 
diabetic rats are different, even though the clinical 
hemodynamic signs may not be different.
Picker et al found an increase in HR and a signifi-
cant correlation between decreased HRV and a de-
crease in HF power, and concluded that the primary 
effect of sevoflurane anesthesia was decreased para-
sympathetic activity [35]. It has also been reported 
that there is an increase in HR with sevoflurane and 
a correlation between the decrease in HF power and 
HRV [36]. Feld et al reported the effect of desflurane 
on vagal tone, and HRV was attenuated in a manner 
similar to sevoflurane [37]. All of these studies sug-
gest that volatile anesthetics decrease vagal tone and 
HRV in a similar way, although there may be subtle 
differences between the drugs. Our results are differ-
ent from previous studies in that the three volatile 
anesthetics did not show dose-dependent decreased 
vagal tone and HRV in either group. However, the 
volatile anesthetic effects on sympathetic vasomotor 
activity and cardiac sympathetic modulation were 
more consistent in both groups. These volatile anes-
thetics dose-dependently inhibit sympathetic nervous 
activity but have mild effects on parasympathetic mod-
ulation during inhalation anesthesia. The variability 
between our study and previous studies may have 
Fig. 3 — Comparison of parameters between control and 
streptozotocin (STZ)-induced diabetic rats with sevoflurane 
anesthesia. *p < 0.05 compared with the control group. -- 
control group; -- STZ-induced diabetic group. MBP = mean 
blood pressure; BLF = low frequency of blood pressure var-
iability; HR = heart rate; HF = high frequency; LF% = normal-
ized low frequency (nu); AW = awake stage; MAC = minimal 
alveolar concentration; PA30 = post-anesthesia 30 minutes; 
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been caused by a difference in experimental spe-
cies and methods of collection and analyzing data. 
Future studies need to extend our methods to clinical 
patients.
In conclusion, we demonstrated the effects of 
three different volatile anesthetics on autonomic reg-
ulation in STZ-induced diabetic animals. Sympathetic 
vasomotor activity (BLF) and cardiac sympathetic ac-
tivity (LF%) may be early signs of hemodynamic 
change in IDDM patients during anesthesia and emer-
gence. These results may provide some suggestions 
on the clinical choice of anesthetic in IDDM patients 
receiving anesthesia.
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